Frank X. Leonard - 01 Nov 2022 Form 4 Insider Report for NovoCure Ltd (NVCR)

Role: President, CNS Cancers US
Signature: By: /s/ Steven Robbins, Attorney in Fact for Frank X. Leonard
Issuer symbol: NVCR
Transactions as of: 01 Nov 2022
Net transactions value: +$849,779
Form type: 4
Filing time: 03 Nov 2022, 16:42:24 UTC
Previous filing: 17 Oct 2022
Next filing: 09 Jan 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	NVCR	Ordinary Shares	Award	$0	+6,830	+16%	$0.000000	50,456	01 Nov 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	NVCR	Options to Buy Ordinary Shares	Award	$849,779	+11,609		$73.20	11,609	01 Nov 2022	Ordinary Shares	11,609	$73.20	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents restricted share units that are scheduled to vest in equal installments on each of November 1, 2023, 2024 and 2025, subject to the reporting person's continued employment through such dates.
F2	Options to buy 11,609 ordinary shares will vest and become exercisable in equal installments on each of November 1, 2023, 2024, 2025 and 2026, subject to the reporting person's continued employment through such dates.